Winokur Sara T, Chen Yi-Wen, Masny Peter S, Martin Jorge H, Ehmsen Jeffrey T, Tapscott Stephen J, van der Maarel Silvere M, Hayashi Yukiko, Flanigan Kevin M
Department of Biological Chemistry, 202 Sprague Hall, University of California, Irvine, CA 92697, USA.
Hum Mol Genet. 2003 Nov 15;12(22):2895-907. doi: 10.1093/hmg/ddg327. Epub 2003 Sep 30.
The neuromuscular disorder facioscapulohumeral muscular dystrophy (FSHD) results from integral deletions of the subtelomeric repeat D4Z4 on chromosome 4q. A disruption of chromatin structure affecting gene expression is thought to underlie the pathophysiology. The global gene expression profiling of mature muscle tissue presented here provides the first insight into an FSHD-specific defect in myogenic differentiation. FSHD expression profiles generated by oligonucleotide microarrays were compared with those from normal muscle as well as other types of muscular dystrophies (DMD, aSGD) in order to determine FSHD-specific changes. In addition, matched biopsies (affected and unaffected muscle) from individuals with FSHD served to monitor expression changes during the progression of the disease as well as to diminish non-specific changes resulting from individual variability. Among genes altered in an FSHD-specific and highly significant manner, many are involved in myogenic differentiation and suggest a partial block in the normal differentiation program. Indeed, many of the transcripts affected in FSHD represent direct targets of the transcription factor MyoD. Additional mis-expressed genes confirm a diminished capacity to buffer oxidative stress, as demonstrated in FSHD myoblasts. This enhanced vulnerability of proliferative stage myoblasts to reactive oxygen species is also disease-specific, further implicating a defect in FSHD muscle satellite cells. Importantly, none of the genes localizing to the FSHD region at 4q35 were found to exhibit a significantly altered pattern of expression in FSHD muscle. This finding was corroborated by expression analysis of FSHD muscle using a custom cDNA microarray containing 51 genes and ESTs from the 4q35 region. Disruptions in FSHD myogenesis and oxidative capacity may therefore not arise from a position effect mechanism as has been previously suggested, but rather from a global effect on gene regulation. Improper nuclear localization of 4qter is discussed as an alternative model for FSHD gene regulation and pathogenesis.
神经肌肉疾病面肩肱型肌营养不良症(FSHD)是由4号染色体q臂上的亚端粒重复序列D4Z4的整段缺失引起的。染色质结构的破坏影响基因表达被认为是其病理生理学的基础。本文展示的成熟肌肉组织的全基因组表达谱首次揭示了FSHD在成肌分化方面的特异性缺陷。将寡核苷酸微阵列生成的FSHD表达谱与正常肌肉以及其他类型的肌营养不良症(DMD、aSGD)的表达谱进行比较,以确定FSHD的特异性变化。此外,来自FSHD患者的匹配活检样本(患病和未患病肌肉)用于监测疾病进展过程中的表达变化,并减少个体差异导致的非特异性变化。在以FSHD特异性且高度显著的方式改变的基因中,许多基因参与成肌分化,并提示正常分化程序存在部分阻滞。实际上,FSHD中受影响的许多转录本代表转录因子MyoD的直接靶点。其他错误表达的基因证实了缓冲氧化应激的能力下降,正如在FSHD成肌细胞中所证明的那样。增殖期成肌细胞对活性氧的这种增强的易感性也是疾病特异性的,进一步暗示FSHD肌肉卫星细胞存在缺陷。重要的是,未发现定位于4q35的FSHD区域的任何基因在FSHD肌肉中表现出明显改变的表达模式。使用包含来自4q35区域的51个基因和EST的定制cDNA微阵列对FSHD肌肉进行表达分析,证实了这一发现。因此,FSHD成肌和氧化能力的破坏可能并非如先前所认为的那样源于位置效应机制,而是源于对基因调控的全局影响。4qter的核定位不当被讨论为FSHD基因调控和发病机制的一种替代模型。